Phaseline

Targets › FGG

FGG (Fibrinogen gamma chain): drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 3; Other; next expected readout Dec 2026.

Together with fibrinogen alpha (FGA) and fibrinogen beta (FGB), polymerizes to form an insoluble fibrin matrix. Has a major function in hemostasis as one of the primary components of blood clots. (UniProt, P02679)

Open in Phaseline: the race on FGG, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Corza MedicalFibrinogen, Human
Fibrinogen exogenous protein
FGA, FGB, FGGPhase 3HemorrhageDec 2026

Conditions

Hemorrhage (1)

Modalities

mixed (1)

Companies

Corza Medical (1)

Related targets

FGA (1) FGB (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.